drugset / Trial / NCT02455596
Recombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine Tumors
Phase 2
Unknown
20 enrolled
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of recombinant anti-tumor and anti-virus protein for injection in treating patients with advanced neuroendocrine tumors who have failed standard treatment or are unable to receive standard treatment.
Timeline
- Start
- 2015-05
- Primary completion
- 2016-10
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Novaferon | Protein / enzyme biologic | 30 ug | Intramuscular |